Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNA binding motif protein 7 (RBM7) is a human RNA-binding protein encoded by the _RBM7_ gene. It is best characterized as a core component of the nuclear exosome targeting (NEXT) complex, which operates in the nucleus to direct specific non-coding RNAs, including promoter-upstream transcripts, enhancer RNAs, and certain extended RNA products, for degradation by the nuclear exosome[1][2][6]. RBM7 contains an RNA recognition motif (RRM) that binds with selectivity for uridine-rich sequences and interacts with proteins such as ZCCHC8 and hMTR4 as part of the NEXT complex, as well as spliceosomal components like SAP145[1]. Through these interactions, RBM7 facilitates the coupling of RNA processing, degradation, and possibly alternative splicing events, although it is not a general splicing factor[1]. There are currently no clinically approved drugs targeting RBM7, nor is it widely considered a therapeutic receptor, enzyme, or transporter.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA binding motif protein 7 (RBM7).